Skip to main content
. 2019 Jul 25;156(6):1111–1119. doi: 10.1016/j.chest.2019.06.035

Table 2.

Reductions in Dlco and FEV1 Are Associated With Increased COPD Morbidity

Outcome Dlco % Predicted
FEV1 % Predicted
Regression Coefficient (95% CI) P Value Regression Coefficient (95% CI) P Value
CAT score 0.53 (0.33 to 0.73) < .001 1.16 (0.96 to 1.36) < .001
SGRQ score 1.67 (1.23 to 2.1) < .001 2.94 (2.58 to 3.31) < .001
 Activity 2.58 (1.74 to 3.41) < .001 3.99 (3.48 to 4.51) < .001
 Impact 1.3 (0.86 to 1.74) < .001 2.25 (1.86 to 2.64) < .001
 Symptom 1.23 (0.70 to 1.76) < .001 3.33 (2.93 to 3.72) < .001
SF-36 Physical Function –0.89 (–1.18 to –0.6) < .001 –1.29 (–1.58 to –1.00) < .001
SF-36 Mental 0.03 (–0.37 to 0.42) .900 –0.01 (–0.31 to 0.31) .954
6MWD, feet –45.35 (–58.21 to –32.48) < .001 –43.26 (–48.36 to –38.15) < .001
Resting Spo2, % –0.22 (–0.38 to –0.05) .012 –0.19 (–0.24 to –0.14) < .001

Associations are per 10% decrease in percent predicted Dlco or percent predicted FEV1. Models (N = 1,564) include age, sex, BMI category, ethnicity, education, smoking pack-years, smoking status, anemia status, diabetes status, congestive heart failure status, sleep apnea status, %LAA-950 (emphysema), percent predicted FEV1, and percent predicted Dlco. See Table 1 legend for expansion of abbreviations.